A 10-year serogroup B meningococcal disease epidemic in New Zealand: Descriptive epidemiology, 1991-2000

Journal of Paediatrics and Child Health

Volumn 37, Issue 5 SUPPL., 2001, Pages 13-19

  Baker, M G ^a   Martin, D R ^a   Kieft, C E M ^a   Lennon, D ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

ADOLESCENT; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIC; FATALITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; IMMUNITY; INFANT; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORBIDITY; NEW ZEALAND; POPULATION RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 0034782182     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00722.x     Document Type: Conference Paper

References (39)

1. Meningococcal disease epidemiology and control in New Zealand
2. Meningococcal disease high rate continues
3. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4
4. The evolving meningococcal disease epidemic in New Zealand
5. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993-95: Estimated risks of further cases in household and educational settings
6. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies
7. PorA-specific PCR-AREA of meningococcal DNA in patient specimens confirms epidemic strain involvement
8. Successful vaccine intervention in a group A meningococcal outbreak in Auckland, NZ
9. Australia's notifiable diseases status, 1998. Annual report of the National Notifiable Diseases Surveillance System
10. Surveillance of invasive meningococcal disease in Canada, 1995-96
11. The changing epidemiology of meningococcal disease in the United States, 1992-96
12. Hospitalisations and fatalities from notifiable communicable diseases in 1999
13. Meningococcal disease in Auckland New Zealand, 1992-94
14. Management of an outbreak of meningococcal meningitis in a Sudanese refugee camp in Northern Uganda
15. Serogroup B meningococcal disease: New outbreaks, new strategies
16. Epidemic serogroup B meningococcal disease in Oregon: The evolving epidemiology of the ET-5 strain
17. Meningococcal disease in Norway 1992-95. Epidemiology and fatality
18. Efficacy, safety, and immuno-genicity of a meningococcal group B (15:P1.4) outer membrane protein vaccine in Iquique, Chile
19. Neisseria meningitidis serogroup B. emergence of the ET-5 complex
20. Meningococcal disease in the Netherlands, 1958-90: A steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis
21. Molecular epidemiology of recent Belgian isolates of Neisseria meningitidis Serogroup B
22. Epidemic meningococcal disease in New Zealand; epidemiology and potential for prevention by vaccine
23. Vaccines for prevention of meningococcal disease
24. Phase I clinical trial with a hexavalent PorA containing outer membrane vesicle vaccine
25. Vaccine against group B Neisseria meningitidis. Protection trial and mass vaccination results in Cuba
26. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile
27. Production, characterization and control of MenB-vaccine 'Folkehelsa': An outer membrane vesicle vaccine against group B meningococcal disease
28. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine
29. Household crowding a major risk factor for meningococcal disease in Auckland children
30. Smoking, the environment and meningococcal disease: A case control study
31. Tobacco smoke as a risk factor for meningococcal disease
32. Maternal cigarette smoking and invasive meningococcal disease: A cohort study among young children in metropolitan Atlanta, 1989-96
33. Unbiased evidence on early treatment of suspected meningococcal disease
34. Early treatment with parenteral penicillin in meningococcal disease
35. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: Report of a 1997 survey